Coherus BioSciences, Inc. earnings per share and revenue

CHRS earnings per share for the last quarter are -0.09 USD whereas the estimation was -0.16 USD which accounts for 44.91% surprise. Company revenue for the same period amounts to 70.77 M USD despite the estimated figure of 58.98 M USD. Estimated earnings per share for the next quarter are -0.31 USD, and revenue is expected to reach 44.95 M USD. Also watch annual changes over time to get a bigger picture of CHRS earnings per share and revenue dynamics.